Delivery of siRNA using hyaluronic acid-guided nanoparticles for downregulation of CXCR4.
Beste Çağdaş TunalıEda ÇelikFatma Azize Budak YıldıranMustafa TürkPublished in: Biopolymers (2023)
In this study, effective transport of small interfering RNAs (siRNAs) via hyaluronic acid (HA) receptor was carried out with biodegradable HA and low-molecular weight polyethyleneimine (PEI)-based transport systems. Gold nanoparticles (AuNPs) capable of giving photothermal response, and their conjugates with PEI and HA, were also added to the structure. Thus, a combination of gene silencing, photothermal therapy and chemotherapy, has been accomplished. The synthesized transport systems ranged in size, between 25 and 690 nm. When the particles were applied at a concentration of 100 μg mL -1 (except AuPEI NPs) in vitro, cell viability was above 50%. Applying radiation after the conjugate/siRNA complex (especially those containing AuNP) treatment, increased the cytotoxic effect (decrease in cell viability of 37%, 54%, 13%, and 15% for AuNP, AuPEI NP, AuPEI-HA, and AuPEI-HA-DOX, respectively) on the MDA-MB-231 cell line. CXCR4 gene silencing via the synthesized complexes, especially AuPEI-HA-DOX/siRNA was more efficient in MDA-MB-231 cells (25-fold decrease in gene expression) than in CAPAN-1 cells. All these results demonstrated that the synthesized PEI-HA and AuPEI-HA-DOX conjugates can be used as siRNA carriers that are particularly effective, especially in the treatment of breast cancer.
Keyphrases
- hyaluronic acid
- cancer therapy
- cell cycle arrest
- gold nanoparticles
- gene expression
- drug delivery
- induced apoptosis
- dna methylation
- squamous cell carcinoma
- photodynamic therapy
- cell proliferation
- breast cancer cells
- cell death
- young adults
- rectal cancer
- oxidative stress
- combination therapy
- locally advanced
- endoplasmic reticulum stress
- radiation therapy
- reduced graphene oxide